← Back to Clinical Trials
Recruiting NCT06164483

NCT06164483 Auditory Functions in Patients With Multiple Sclerosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06164483
Status Recruiting
Phase
Sponsor University of Catania
Condition Multiple Sclerosis
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-05-11
Primary Completion 2027-12-30

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 40 Years
Study Type OBSERVATIONAL
Interventions
Auditory testCSF sampling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-05-11 with a primary completion date of 2027-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will analyze the auditory functions of patients with Multiple Sclerosis using auditory tests like pure tone auditory test, speech perception test, Auditory Brain Response (ABR) and Distortion Product Otoacustic Emission (DPOAE). CSF will be collected by lumbar puncture and analyzed looking for inflammatory markers. The results of DPOAE and CSF will be correlated to identify statistically significant correlation.

Eligibility Criteria

Inclusion Criteria * age \>18 and \<50, * no history of hearing loss, * no psychiatric condition * no familial history of otosclerosis/deafness/genetic hearing loss * patients with PD and/or MS. Exclusion Criteria * Conductive hearing loss * stroke \< 2 years * cardiovascular disease non under control * diabetes * hypotensive disorders * alcohol abuse * recreational drug consumption * epilepsy

Frequently Asked Questions

Who can join the NCT06164483 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06164483 currently recruiting?

Yes, NCT06164483 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Catania to inquire about joining.

Where is the NCT06164483 trial being conducted?

This trial is being conducted at Catania, Italy.

Who is sponsoring the NCT06164483 clinical trial?

NCT06164483 is sponsored by University of Catania. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology